GE HealthCare Technologies Inc.

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-24 pm EDT			5-day change	1st Jan Change
71.98 ^USD	+1.15%		-1.21%	-7.93%

Jun. 24	Sector Update: Health Care Stocks Advance Late Afternoon	MT
Jun. 24	GE Healthcare Says FDA Approves Updated Label for Vizamyl Imaging Agent	MT

GE HealthCare Technologies Keeps Quarterly Cash Dividend at $0.03/Share, Payable on May 15 to Shareholders on April 19

Published on 03/22/2024 at 11:13, updated on 03/22/2024 at 11:38

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about GE HealthCare Technologies Inc.

Sector Update: Health Care Stocks Advance Late Afternoon	Jun. 24	MT
GE Healthcare Says FDA Approves Updated Label for Vizamyl Imaging Agent	Jun. 24	MT
FDA Approves Expanded Indications for GE Healthcare's Vizamyl Pet Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients	Jun. 24	CI
GE HeathCare: to present its innovations in cardiology	Jun. 23	CF
GE HealthCare Enhances Cardiovascular Diagnostics with Innovative Molecular Imaging Solutions Showcases at SNMMI 2025	Jun. 23	CI
GE HealthCare Renews Research Collaboration with Stanford Medicine	Jun. 19	CI
GE Healthcare Advances Precision Care with MIM Encore? to Deliver Next-Generation Digital Imaging and Workflow Solutions	Jun. 12	CI
GE HealthCare Technologies Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10:00 AM	Jun. 10
Some of the biggest splits in Corporate America	Jun. 09	RE
Capital Research Global Reports 4.8% Passive Stake In GE Healthcare As Of May 30	Jun. 06	RE
GE HealthCare Files For Offering Of $650 Million 4.800% Senior Notes Due 2031	Jun. 03	RE
DBS Bank Adjusts Price Target on GE Healthcare Technologies to $90 From $80, Maintains Buy Rating	Jun. 02	MT
Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $85 From $82, Maintains Buy Rating	Jun. 02	MT
GE HealthCare Technologies Inc. Updates NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer	May. 30	CI
GE Healthcare Says Updated NCCN Guidelines Recommend Use of FES PET Imaging for Breast Cancer	May. 30	MT
GE HealthCare Technologies Inc. Launches CleaRecon DL, Introducing Ai-Based 3D Reconstruction to the Interventional Suite	May. 15	CI
GE HealthCare Technologies Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08:00 AM	May. 13
GE HealthCare Says FDA Approves Use of Optison Ultrasound Enhancing Agent in Children	May. 13	MT
GE Healthcare, Raydiant Oximetry to Advance Fetal Oxygen Saturation Technology	May. 13	MT
GE HealthCare Technologies Inc. Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent	May. 13	CI
GE Healthcare Technologies Inc. and Raydiant Oximetry, Inc. Accelerate Innovation in Fertal Oxy Sension Technology	May. 13	CI
GE Healthcare Unveils Ultra-Premium, High-Performance Gradium 1.5T MRI System	May. 12	CI
GE HealthCare: presents its new MRI scanner at the ISMRM conference	May. 12	CF
HSBC Adjusts GE Healthcare Technologies Price Target to $98 From $100, Maintains Buy Rating	May. 08	MT
Argus Adjusts Price Target on GE Healthcare Technologies to $90 From $110, Maintains Buy Rating	May. 08	MT

Chart GE HealthCare Technologies Inc.

Duration

Period

GEHC: Dynamic Chart

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. The Company provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.

Employees

53,000

Sector

Advanced Medical Equipment & Technology

Calendar

Jul. 28 - Q2 2025 Earnings Release (Projected)

More about the company